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Standard indications for carotid endarterectomy
(CEA) have been established.1,2 The American Heart
Association Consensus report further elaborated spe-
cific guidelines for proceeding with CEA depending
on the patient’s condition. This was based on the
expected benefits of surgical therapy over medical
management in different patient groups. The com-
bined stroke and death rate for patients with sympto-
matic stenosis who undergo surgical procedures
should be less than 6% and for patients with asympto-
matic stenosis who undergo surgical procedures
should be less than 3%.3 Accordingly, CEA must be
performed with a low morbidity rate to be beneficial.
Reports on patient characteristics and comorbidities
and how they may effect the perioperative risks of CEA
have not been evaluated specifically in this context.
Renal insufficiency (RI), often a complication of
diabetes or hypertension, previously has been evalu-
ated in the context of outcomes after infrainguinal
reconstruction. Studies have demonstrated that
patency and limb salvage rates in patients with RI
approximate those seen in patients with normal renal
function, although morbidity and mortality rates are
increased and life expectancy is decreased.4
Two previous studies have evaluated the impact
of RI on results of CEA.5,6 Both identified RI as a
risk factor for increased rates of stroke and death. In
one study, patients with creatinine levels greater than
2.9 mg/dL had a stroke rate of 43%, and only one
patient was alive and stroke free 6 months after
CEA. They concluded that in patients with severe
RI, CEA might be inappropriate in most circum-
stances.6 The purpose of this study was to review our
experience with CEA in patients with RI.
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Purpose: Higher complication rates have been reported in patients with renal insuffi-
ciency (RI) undergoing peripheral vascular surgery. Little attention has been paid specif-
ically to carotid endarterectomy (CEA) in patients with RI where the risk/benefit con-
siderations are very sensitive to small increases in postoperative complications. 
Methods: One thousand one consecutive CEAs performed since 1990 were reviewed from
our vascular registry, and 73 CEAs on patients with RI were identified. For comparison,
two groups were established: group I (n = 928), normal renal function (creatinine level,
<1.5 mg/dL); and group II (n = 73), RI (creatinine level, ‡ 1.5 mg/dL).
Results: Differences in the nonfatal stroke rates and combined stroke and death rates
were statistically significant (P < .02) between the groups: group I (1.08% and 1.18%)
and group II (5.56% and 6.94%) respectively. Both groups were similar in regard to
operative indications. In addition with the comparison of group I to group II, there was
a statistically significant increase in hematoma rate, 1.61% versus 12.5% (P < .001), total
cardiac morbidity, 1.72% versus 6.94% (P = .003), and total complications, 6.24% ver-
sus 36.1% (P = .001). Multivariate analysis demonstrated pre-existing RI to be the only
significant predictor for perioperative stroke and hematoma. 
Conclusion: Patients with preoperative RI are at a higher, but not prohibitive, risk for
stroke and death after CEA than patients with normal renal function. They are also at
risk for hematoma formation, cardiac morbidity, and overall complications. Care in selec-
tion of these patients for CEA must be emphasized. (J Vasc Surg 1999;29:1006-11.)
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PATIENTS AND METHODS 
In January of 1990 a computerized vascular reg-
istry was established where data from all patients
who have undergone vascular procedures at the
West campus of the Beth Israel Deaconess Medical
Center were prospectively entered. For purpose of
this article, we reviewed all consecutive patients who
underwent CEA from January 1990 to August
1997. Those patients who underwent combined
procedures (coronary artery bypass grafting
[CABG]), aortic arch procedures, or CEA for recur-
rent stenosis were excluded from this review. 
To compare patients with RI to those patients
with normal renal function, two groups were estab-
lished: group I, normal renal function (n = 928),
creatinine level, less than 1.5 mg/dL; and group II,
RI (n = 73), creatinine level, 1.5 mg/dL or more.
The overall RI cohort contained three patients who
were receiving hemodialysis or peritoneal dialysis
therapy and one patient who had a previous renal
transplant. Creatinine levels expressed as milligrams
per deciliter were the most recent preoperative val-
ues for each patient, obtained by computer or chart
review. Patient characteristics and preoperative risk
factors were also evaluated, including previous his-
tory of myocardial infarction (MI) or congestive
heart failure (CHF) and the presence of diabetes
mellitus. Preoperative risk factors were obtained by
registry review.
Review of the vascular registry allowed classifica-
tion of the indications for CEA as asymptomatic or
symptomatic, which included transient ischemic
attacks, episodes of amaurosis fugax, and completed
stroke. Nonlateralizing symptoms or unclear symp-
toms were characterized as asymptomatic for the pur-
pose of this report. Length of stay (LOS) was defined
as the total days the patient remained in the hospital
after CEA, including those days incurred by an addi-
tional consecutive procedure such as a CABG.
Most procedures were performed by vascular fel-
lows and general surgical residents under direct
supervision of five staff vascular surgeons. Most of
the patients underwent general endotracheal anes-
thesia with routine shunting, but some CEAs were
performed with regional anesthesia. Patching was
used at the discretion of the individual surgeons on
the basis of the diameter of the internal carotid
artery. A satisfactory technical result was confirmed
by intraoperative assessment with a hand-held
Doppler scanning device. Intraoperative arteri-
ograms were performed in those patients who were
taken back to the operating room for evaluation of
an ipsilateral perioperative neurologic deficit. Some
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patients had both left and right CEAs at different
times during the study interval. Risk factors were
entered separately at the time of each individual
operation.
Statistics. Statistical analysis was performed with
the Minitab computer program (State College,
Penn). Categoric variables were compared with the
Chi-squared test, and continuous variables were
compared with the Student t test. Those variables
that were associated with postoperative outcome at
P < .05 were then selected for multivariate analysis
with the use of binary logistic regression analysis. P
< .05 was considered significant.
Patient demographics. The preoperative char-
acteristics of the patients are listed in Table I by
group. There was no significant difference in the
operative indications between the groups. More
patients in group II, however, had pre-existing
comorbidities of diabetes, hypertension, and CHF. 
There was no statistical difference in the per-
centage of patients in either group with preoperative
contralateral carotid artery occlusion. There was no
statistically significant difference in the type of anes-
thesia or in the use of indwelling shunts or patches
between the groups (Table II).
RESULTS
Overall complications. There were a total of 84
complications (8.4%) overall in the 1001 operations
performed. Group I had 58 complications (6.24%)
in 46 patients (4.96%) versus 26 complications
(36.1%) in 22 patients (30.1%) in group II (P =
.001). Overall, there were 14 strokes (1.4%), 4 tran-
sient ischemic attacks (0.4%), and 2 deaths (0.2%).
Strokes. All strokes were ipsilateral to the side of
the CEA. In each group, there was one perioperative
stroke in a patient who had a pre-existing contralat-
eral carotid artery occlusion, yielding rates of 1.72%
and 16.7%, respectively.
Table I. Preoperative risk factors, demographics,
and symptoms of the patients in each group 
Group I Group II
(n = 928) (n = 73) P value 
Male patients (%) 60.6 (562) 63.0 (46) .68
Female patients (%) 39.4 (366) 37.0 (27) .68
Symptomatic patients (%) 58.0 (535) 55.0 (40) .8
Asymptomatic patients (%) 42.0 (393) 45.0 (33) .8
Diabetes (%) 37.0 (345) 53.0 (39) .006*
Hypertension (%) 69.0 (644) 86.0 (63) .002*
CHF (%) 8.5 (78) 35.5 (26) .001*
MI (%) 27.5 (256) 31.5 (23) .49
Age (yrs) 70.14 (928) 71.52 (73) .8
Ten strokes (1.08%) occurred in group I. Of
these 10 strokes, eight (80%) occurred in sympto-
matic patients, yielding a stroke rate of 0.51% in
asymptomatic patients and 1.5% in symptomatic
patients. Seven of the 10 patients in group I under-
went re-exploration. In four cases there was fresh
clot on the internal carotid surface in the area of the
endarterectomy with no identifiable defect, one inti-
mal flap at the distal endpoint, and one distal kink
with flow obstruction. In one case, no operative
defect was found. In the three other patients, the
strokes were due to heparin-induced thrombocy-
topenia in one patient, an intracerebral bleed in one
patient, and hypoperfusion or emboli in the last
patient, who had a patent internal carotid artery by
postoperative duplex scan. 
Four strokes occurred in group II, for an inci-
dence of 5.56%. Three of these four strokes (75%)
occurred in symptomatic patients. The stroke rate
was 3.03% in asymptomatic patients and 7.5% in
symptomatic patients in group II. Two of the four
patients in group II underwent re-exploration, and
both patients were found to have an intimal flap at
the distal endpoint. In the two patients who did not
undergo re-exploration, hypoperfusion or emboli
was presumed to be the cause because they both had
normal postoperative internal carotid arteries by
duplex scan. 
Overall, there was a statistically significant
increase in the perioperative stroke rate in patients
with RI as compared with those with normal renal
function (1.08% vs 5.56%; P = .002; Table III). 
By multivariate analysis, RI still remained a sig-
nificant predictor of postoperative strokes (P = .006;
odds ratio, 5.32; 95% confidence interval, 1.63-
17.41; Table IV).
The sequelae of the strokes were as follows:
group I, four deficits (40%) that did not require any
inpatient rehabilitation, two deficits (20%) that
required a period of inpatient rehabilitation, and
four deficits (40%) that required intensive rehabilita-
tion and in one case tracheostomy and gastrostomy
tube placement; group II, one stroke (25%) resulted
in the patient requiring long-term care. This stroke
ultimately led to the patient’s death 2 months later
in the rehabilitation center. 
Death. There were two deaths within 30 days
after surgery. In group I, one female patient (0.11%)
died 8 days after surgery of complications of a MI.
In group II, one male patient (1.39%) with a creati-
nine level of 7.6 mg/dL died in the recovery room
of a suture line bleed and neck hematoma resulting
in respiratory arrest.
Cardiac morbidity. There was a statistically sig-
nificant increase in postoperative CHF (P = .001) and
total cardiac morbidity (P = .003) in group II. All
three patients in group II who experienced the devel-
opment of postoperative CHF had a prior history of
CHF. One episode of CHF was due to a postopera-
tive MI, and two episodes of CHF were the result of
myocardial ischemia. In contrast, in group I, only two
of the five patients who experienced the development
of postoperative CHF had a history of prior CHF,
and only two of five of the episodes appeared to be a
result of MI. Although univariate analysis demon-
strated a significant increase in postoperative CHF in
those patients with RI, multivariate analysis did not
demonstrate RI to be a predictor of CHF.
Hematoma. There were a total of 24 neck
hematomas (2.4%). Thirteen hematomas (54%)
required re-exploration for evacuation. One resulted
in a perioperative death. All others resulted in no
additional neurologic or cardiac morbidity. Patients
in group II were more likely to experience the devel-
opment of wound hematomas; however, the rate of
re-exploration was not significantly different between
the groups. By multivariate analysis, RI was the only
statistically significant predictor of hematoma (P <
.0005; odds ratio, 6.78; 95% confidence interval,
2.67-17.17).
DISCUSSION
Reports on patients with RI undergoing CEA
have only been recently forthcoming. One report
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Table II. Type of anesthesia, shunt, and patch used and the presence of internal carotid artery occlusions
contralateral to the operative side in each of the groups 
Contralateral occlusion (%) GETA (%) Regional (%) Shunt (%) Patch (%)
Group I (n = 928) 6. 25 74.5 25.5 67.4* 41.5
Group II (n = 73) 8.22 79.5 20.5 67.6* 30.1
P value .5 .34 .34 .97 .06
GETA, General endotracheal anesthesia.
*Data were unavailable on 41 patients in group I and 2 patients in group II.
identified 222 procedures in patients on hemodialy-
sis in a review of 9795 CEAs. Hemodialysis was
identified as an independent risk factor for increases
in both perioperative stroke rate and death.5 In
another retrospective report, the results of 21 CEAs
in patients with a creatinine level greater than 1.5
mg/dL were compared with CEA in patients with
normal renal function. In a subgroup of 7 CEAs 
performed on 6 patients with creatinine levels
greater than 2.9 mg/dL, the stroke rate was 43%.6
The current study was undertaken to better
define whether RI adversely effects expected out-
comes for CEA. Our results reveal an increase in
stroke, death, cardiac morbidity, and hematoma for-
mation and a marked increase in overall complica-
tions in the patients with RI. Conversely, although
95% of patients with normal renal function under-
went CEA without any complications, less than 70%
of patients with RI did so. One death occurred in
each group, making conclusions about death diffi-
cult from this study.
There was a substantially higher rate of cardiac
morbidity in the RI group. This increase in cardiac
morbidity is likely due to the higher degree of pre-
existing ischemic cardiac disease in these patients.
Although multivariate analysis did not select RI as a
significant predictor of postoperative CHF, it was far
more frequent both before and after operation in these
patients. Careful management of perioperative volume
status including considering early postoperative dialy-
sis to reduce volume overload is therefore a prudent
management strategy in patients with pre-existing RI. 
Perioperative strokes were five times more com-
mon in patients with RI in spite of having similar
numbers of patients undergoing surgery for sympto-
matic carotid disease and having similar incidences of
contralateral occlusion to those patients with normal
renal function. Shunting and patching and anesthet-
ic techniques were also comparable in both groups.
Patients with RI may have a higher rate of intracra-
nial disease although this could not be determined in
this present study. In addition, patients with RI were
more likely to have hypertension and diabetes.
Although we have previously shown that the stroke
rate is the same in the presence or absence of dia-
betes,7 several studies have indicated hypertension as
a predictor of postoperative neurologic morbidity.8,9
In this current study, however, multivariate analysis
demonstrated that RI was the only statistically signif-
icant factor predicting postoperative stroke.
There was an increase in neck hematomas in
patients with RI, but because coagulation function
was not routinely evaluated in these patients, con-
clusions are difficult to draw. The high rate of com-
plications resulted in an increase in the average LOS
from 2.89 days to 6.1 days in group II patients.
Additional factors increasing the LOS in patients
with RI were the need for additional, consecutive
procedures (CABG or peripheral bypass).
This study has several shortcomings. Data were
entered into the database prospectively but reviewed
retrospectively. In addition, it is possible that selec-
tion bias may have excluded some patients with
severe RI from CEA, which could have made the
differences in outcome even more apparent than the
findings in this analysis. Only three patients with
dialysis-dependent renal failure were available for
analysis, making conclusions about this subset diffi-
cult. From the available results, however, the com-
plication rates did not appear to increase propor-
tionally with an increase in creatinine level. In the
three patients with dialysis-dependent renal failure,
the only complication was one reoperation for
hematoma evacuation. Also, the overall small num-
ber (7.3%) of patients with RI made it impossible to
determine whether stratifying postoperative risks by
the severity of the renal failure in this patient cohort
is valid. Nonetheless, these data do reveal important
differences in these patients, which are relevant to
patient selection and management. 
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Table III. Complication rates in each group of
patients
Group I Group II
(n = 928) (n = 73) P value 
Stroke (%) 1.08 (10) 5.56 (4) .002*
Death (%) 0.11 (1) 1.39 (1) .019*
MI (%) 0.43 (4) 1.39 (1) .26
CHF (%) 0.54 (5) 4.20 (3) .001*
Arrhythmia (%) 0.75 (7) 1.39 (1) .56
All cardiac (%) 1.72 (16) 6.94 (5) .003*
Hematoma (%) 1.61 (15) 12.50 (9) .001*
LOS (days) 2.89 (0-32) 6.18 (1-62) .012*
All complications (%) 6.24 (58) 36.11 (26) .001*
Table IV. Preoperative predictors of postoperative
stroke
95% Confidence
P value Odds ratio interval
RI .006 5.32 1.63-17.41
Hypertension .601 0.75 0.25-2.24
Symptomatic stenosis .122 0.36 0.10-1.31
Sex .785 1.17 0.39-3.51
Diabetes mellitus .372 1.62 0.56-4.65
Age .286 1.03 0.97-1.09
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Currently, we feel that, when evaluating patients
with RI for CEA, surgeons should take into account
the likelihood of higher rates of stroke and other com-
plications. Our stroke rate of 3.03% in asymptomatic
patients and 7.5% in symptomatic patients with RI are
both slightly higher than the benchmark rates of 3%
and 6% proposed by the American Heart Association
and substantially higher than our results of 0.51% and
1.5% in patients with normal renal function. A partic-
ularly difficult group is patients with RI and asympto-
matic carotid stenosis. As noted previously, for CEA
to be beneficial, especially in this group, postoperative
complications must be low. Thus when evaluating
patients with RI and less critical degrees of stenosis or
when associated comorbidities suggest that life
expectancy will be less than 2 years, the surgeon must
carefully consider the indications on a patient-by-
patient basis. Although no definitive conclusions can
be made from this retrospective study, the appropri-
ateness of CEA in patients with RI and other comor-
bidities with asymptomatic stenosis must be ques-
tioned. In addition, patients undergoing CEA with
RI for any indication should be monitored more care-
fully for cardiac complications than patients without
RI and may not be appropriate for “fast tracking” to
very short hospital stays. For the formulation of more
specific guidelines that clarify the role of CEA in these
patients, further prospective data must be accumulat-
ed in patients with RI.
CONCLUSION
Patients with RI have an increased rate of stroke
and major complications after CEA when com-
pared with patients with normal renal function.
Until additional data are available on both the nat-
ural history of carotid disease and the expected
outcomes of CEA in patients with RI, the appro-
priate role of endarterectomy in these patients will
remain unclear. 
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Dr Thomas O’Donnell (Boston, Mass). This is a very
valuable, clinical paper. Obviously, the thing that leaps out
at many of the surgeons in the audience is the high inci-
dence of wound hematoma experienced by a group that
are quite technically proficient. Thus one would question
that the most likely course is something systemic and non-
surgical.
Therefore can you describe what your routine of anti-
coagulation is in these patients?
Do they receive aspirin to the day of surgery? And if
so, would you now withdraw it in this population? Do you
use perioperative low-molecular weight dextran? When
you administer heparin, is it on a per-kilogram dosage or
a uniform dosage? Would you use protamine to reverse the
heparin, particularly in the renal failure group?
Dr Hamdan. As far as aspirin use, I believe that is fair-
ly surgeon dependant. I think for patients who are asymp-
tomatic, most of the surgeons will stop aspirin, preopera-
tively, but I do not think that is necessarily a standard.
Dextran is not routinely used in this practice. And as far as
heparin use, it is, I would say a fairly standard dose, mil-
ligram per kilogram dose. Protamine is not used very
often. But, unfortunately, I do not have all the specifics on
the hematomas in this group, as to what the cause was,
and I think we need to look further at this group, espe-
cially now, when we know about the hematoma increase.
About taking efforts to decrease that rate of hematomas.
Dr John Skillman (Boston, Mass). In the particular
group of patients who have renal failure on dialysis,
because this is often the group of patients who has the
worst prognosis from many points of view, do you have
any data in that group with respect to the correlation
DISCUSSION
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between the degree of renal failure and the incidence of
neurologic complications?
Dr Hamdan. Unfortunately, in this group, which was a
surprise to me, judging from our patient population
undergoing peripheral bypass, only three of the 73
patients had hemodialysis-dependent renal failure. And of
those three patients, only one patient had a complication,
which was a hematoma requiring evacuation. The only
other study, which I listed here, the Cleveland Vascular
Registry, unfortunately, did not give the specific numbers,
but it had 222 patients, at about 10,000, who are on
hemodialysis. And in those patients there was a higher rate
of stroke and mortality, but the exact numbers were not
listed. When I looked at our 73 patients, it did not seem
to me that an increase in creatinine level necessarily pro-
jected a worse complication rate. Broken down, using dif-
ferent levels as a threshold, the fold increase in the com-
plications was fairly similar, which was surprising to me.
Dr Piergiorgio Cao (Perugia, Italy). Because you have
the difference in the other risk factors, like CHF, diabetes,
and hypertension, would you consider to make multivari-
ate analysis to avoid the confounding effects of these other
vascular risk factors? Did you observe any different hyper-
tensive pattern in patients who developed postoperative
hematoma?
Dr Hamdan. That is an excellent point, and multivari-
able analysis is something we are undertaking at this point,
to try to sort that out a little bit better. And as far as post-
operative hypertension, in relation to the hematomas, I do
not have that specific information.
Dr Michael Sobel (Syracuse, NY). Following up on
that same idea, I wonder if really, the serum creatinine level
is a surrogate marker for a complex of risk factors that are
not so easily and precisely identified? Particularly, because
renal function is a continuous variable, and you found, at
least in your analysis, that different degrees of renal failure
did not so clearly correlate with the incidence of complica-
tions. But I wonder if we should not look at it as a kind of
surrogate representative for a host of risk factors that might
alert us to the patient with the worst prognosis?
Dr Hamdan. That is a very valid point. I do not think
from this study that I am trying to intimate that someone
who has a creatinine level of 1.6 should or should not be
operated on based on that fact. But I think it is just another
factor to take into account, especially in the asymptomatic
group where the mortality and morbidity rates need to be
low for the benefits to be realized.
Dr Charles Shoemaker (Newport, RI). My question
relates to selection of patients. In the group who had renal
failure, you had a sub group who were asymptomatic, and
I gather you had a stroke rate of around three, if I am not
mistaken. Now what is the baseline for a person in renal
failure, who is asymptomatic? Is the patient more likely to
have a stroke without surgery? In other words, is the
patient’s natural history to go on to have a major stroke?
Dr Hamdan. That is a very important point, especially
when you are trying to make conclusions about who
should and should not be operated on. Unfortunately, I
am not aware of any natural history studies, specifically
looking at patients with RI in asymptomatic carotid steno-
sis. Obviously, that would be important information,
because if they had an inordinately high stroke rate, high-
er than the 11% at 5 years in a prospective trial, then you
could accept a little bit of higher morbidity rate to do
endarterectomy and still have a benefit. However, I do not
know that information.
Unidentified Speaker. Clearly, you have demonstrated
a group of patients who are more sick with poorer out-
come and have warned us that we have to be careful in
translating our conclusions from other randomized stud-
ies to this particular subgroup. I think you have made a
very valuable contribution there.
